+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Budesonide"

Research Report on China's Mesalazine Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Mesalazine Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
From
Symbicort - Product Thumbnail Image

Symbicort

  • Report
  • July 2018
  • 30 Pages
  • Global
From
Trimbow - Product Thumbnail Image

Trimbow

  • Report
  • July 2018
  • 17 Pages
  • Global
From
Drug Analysis: Symbicort - Product Thumbnail Image

Drug Analysis: Symbicort

  • Drug Pipelines
  • February 2018
  • 27 Pages
  • Global
From
PT010 - Product Thumbnail Image

PT010

  • Report
  • July 2018
  • 20 Pages
  • Global
From
Loading Indicator

Budesonide is a corticosteroid used to treat respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. It is available in both inhalation and oral forms, and is used to reduce inflammation in the airways. Budesonide is a synthetic corticosteroid, meaning it is similar to the hormones produced naturally by the body. It works by reducing inflammation in the airways, which helps to reduce symptoms such as wheezing, coughing, and shortness of breath. Budesonide is a widely used drug in the respiratory market, and is often prescribed as a first-line treatment for asthma and COPD. It is generally well-tolerated and has fewer side effects than other corticosteroids. It is also used in combination with other drugs to treat more severe cases of respiratory diseases. Some companies in the Budesonide market include AstraZeneca, GlaxoSmithKline, Merck, and Teva Pharmaceuticals. Show Less Read more